Wilson Thomas J, Stetler William R, Fletcher Jeffrey J
Department of Neurosurgery, University of Michigan, Ann Arbor, MI 48109-5338, USA.
Clin Neurol Neurosurg. 2013 Jul;115(7):879-82. doi: 10.1016/j.clineuro.2012.08.025. Epub 2012 Sep 1.
To compare cumulative complication rates of peripherally (PICC) and centrally (CICVC) inserted central venous catheters, including catheter-related large vein thrombosis (CRLVT), central line-associated bloodstream infection (CLABSI), and line insertion-related complications in neurological intensive care patients.
Retrospective cohort study and detailed chart review for 431 consecutive PICCs and 141 CICVCs placed in patients under neurological intensive care from March 2008 through February 2010. Cumulative incidence of CRLVT, CLABSI, and line insertion-related complications were compared between PICC and CICVC groups. Risk factors for CRLVT including mannitol therapy during dwell time, previous history of venous thromboembolism, surgery longer than 1h during dwell time, and line placement in a paretic arm were also compared between groups.
During the study period, 431 unique PICCs were placed with cumulative incidence of symptomatic thrombosis of 8.4%, CLABSI 2.8%, and line insertion-related complications 0.0%. During the same period, 141 unique CICVCs were placed with cumulative incidence of symptomatic thrombosis of 1.4%, CLABSI 1.4%, and line insertion-related complications 0.7%. There was a statistically significant difference in CRLVT with no difference in CLABSI or line insertion-related complications.
In neurological critical care patients, CICVCs appear to have a better risk profile compared to PICCs, with a decreased risk of CRLVT. As use of PICCs in critical care patients increases, a prospective randomized trial comparing PICCs and CICVCs in neurological critical care patients is necessary to assist in choosing the appropriate catheter and to minimize risks of morbidity and mortality associated with central venous access.
比较外周置入中心静脉导管(PICC)和中心置入中心静脉导管(CICVC)的累积并发症发生率,包括导管相关的大静脉血栓形成(CRLVT)、中心静脉导管相关血流感染(CLABSI)以及神经重症监护患者中与置管相关的并发症。
对2008年3月至2010年2月期间在神经重症监护下接受治疗的患者连续置入的431根PICC和141根CICVC进行回顾性队列研究和详细的病历审查。比较PICC组和CICVC组中CRLVT、CLABSI以及与置管相关并发症的累积发生率。还比较了两组中CRLVT的危险因素,包括留置期间甘露醇治疗、既往静脉血栓栓塞病史、留置期间手术时间超过1小时以及在瘫痪手臂置管。
在研究期间,共置入431根PICC,症状性血栓形成的累积发生率为8.4%,CLABSI为2.8%,与置管相关的并发症为0.0%。同期,共置入141根CICVC,症状性血栓形成的累积发生率为1.4%,CLABSI为1.4%,与置管相关的并发症为0.7%。CRLVT存在统计学显著差异,而CLABSI或与置管相关的并发症无差异。
在神经重症监护患者中,与PICC相比,CICVC似乎具有更好的风险特征,CRLVT风险降低。随着重症监护患者中PICC使用的增加,有必要进行一项前瞻性随机试验,比较神经重症监护患者中PICC和CICVC,以协助选择合适的导管,并将与中心静脉通路相关的发病和死亡风险降至最低。